Table 2.
Comparison between Moroccans and Egyptians from TCC with regards to demographic, diagnosis, and treatment variables
| Characteristic(N=Egypt,N=Morocco) | Tanta, Egypt (N=71) | Morocco (N=132) | p-valuea |
|---|---|---|---|
| Lives in an urban area (N=62,N=81) | 21 (33.9%) | 26 (32.1%) | 0.8231 |
| Liver Cirrhosis (N=50,N=127) | 14 (28.0%) | 1 (0.8%) | < 0.0001 |
| Family History of Breast Cancer (N=50,N=127) | 1 (2.0%) | 5 (3.9%) | 0.5215 |
| Symptom at Diagnosis | |||
| Palpable mass (N=50,N=125) | 22 (44.0%) | 53 (42.4%) | 0.8468 |
| Nipple retraction(N=50,N=124) | 8 (16.0%) | 10 (8.1%) | 0.1198 |
| Redness or darkness(N=50,N=124) | 0 (0%) | 6 (4.8%) | 0.1134 |
| Treatment Characteristicb (N=53,N=98) | |||
| Chemotherapy and/or radiotherapy | 5 (9.4%) | 20 (20.4%) | 0.0833 |
| Surgery and/or hormone therapy and/or | 43 (81.1%) | 72 (73.5%) | 0.2916 |
| Chemotherapy/radiotherapy |
a
χ2-test.
b
Treatment characteristic not available for 5 patients (9.4%) in Tanta, Egypt, and 6 patients (6.1%) in Morocco.